Document Detail


In summary: satellite symposium on central alpha-adrenergic blood pressure regulating mechanisms.
MedLine Citation:
PMID:  6150004     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This symposium reviewed the fundamental principles, pharmacology, and clinical pharmacology of central alpha-adrenergic blood pressure regulating mechanisms. Fundamental principles Arterial baro- and chemoreceptor signals reach the nucleus of the tractus solitarius (NTS) via vagal and glossopharyngeal afferents. The NTS communicates with sympathetic preganglionic neurons in the spinal cord via centers and tracts in the medulla, pons, and hypothalamus that include an alpha-adrenergic inhibitory network. Descending tracts emphasized in this symposium originate in the C-1 epinephrine cells of the medulla, B-1 and B-3 serotonin cells of the medulla, and A-5 norepinephrine cells of the pons. Transmitters involved are norepinephrine, epinephrine, serotonin, glutamate, and gamma-aminobutyric acid (GABA). Catecholamine enzymes share protein domains in their primary structures and may be coded by linked or single genes. New methods of purifying and locating alpha- and beta-receptors have been developed. Pharmacology Methyldopa, clonidine, and clonidine-like drugs lower blood pressure by stimulating postsynaptic alpha 2-receptors in a brain stem inhibitory network, which down-regulates these receptors. Alpha 1-receptors were found to be higher in normotensive than in hypertensive rats and were increased in the latter by methyldopa administration. Alpha 2-receptors were found to differ in various tissues, which permits the development of highly selective agonists and antagonists. Although alpha-methylnorepinephrine is probably the principal metabolite of methyldopa, alpha-methylepinephrine and alpha-methyldopamine may also contribute. The site of action usually is identified as the NTS. Possible roles for the descending tracts were suggested. Clinical pharmacology Methyldopa, clonidine, guanfacine, and related drugs lower blood pressure principally by CNS mechanisms but peripheral actions may also contribute.(ABSTRACT TRUNCATED AT 250 WORDS)
Authors:
W B Abrams
Related Documents :
3966744 - Clonidine suppression testing in essential hypertension.
3316304 - Comparison of moxonidine and clonidine hcl in treating patients with hypertension.
6139984 - Relaxation of rabbit cerebral arteries in vitro by clonidine. evidence of h2-receptor m...
4042114 - Effect of clonidine and naloxone on the pressor response during contraction of cat hind...
20420724 - Comparison between automatic tube compensation and continuous positive airway pressure ...
20840514 - Effects of different respiratory maneuvers on esophageal sphincters in obese patients b...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Hypertension     Volume:  6     ISSN:  0194-911X     ISO Abbreviation:  Hypertension     Publication Date:    1984 Sep-Oct
Date Detail:
Created Date:  1984-12-28     Completed Date:  1984-12-28     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7906255     Medline TA:  Hypertension     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  II87-93     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Afferent Pathways / physiology
Animals
Antihypertensive Agents / adverse effects
Blood Pressure* / drug effects
Brain / physiology
Clonidine / pharmacology
Epinephrine / physiology
Glossopharyngeal Nerve / physiology
Glutamates / physiology
Glutamic Acid
Guanfacine
Guanidines / pharmacology
Humans
Hypothalamus / physiology
Medulla Oblongata / physiology
Methyldopa / metabolism,  pharmacology
Norepinephrine / metabolism,  physiology
Phenylacetates / pharmacology
Pons / physiology
Pressoreceptors / physiology
Receptors, Adrenergic, alpha / physiology*
Serotonin / physiology
Spinal Cord / physiology
Substance Withdrawal Syndrome
Vagus Nerve / physiology
gamma-Aminobutyric Acid / physiology
Chemical
Reg. No./Substance:
0/Antihypertensive Agents; 0/Glutamates; 0/Guanidines; 0/Phenylacetates; 0/Receptors, Adrenergic, alpha; 29110-47-2/Guanfacine; 4205-90-7/Clonidine; 50-67-9/Serotonin; 51-41-2/Norepinephrine; 51-43-4/Epinephrine; 555-30-6/Methyldopa; 56-12-2/gamma-Aminobutyric Acid; 56-86-0/Glutamic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hemodynamic and cardiac effects of centrally acting antihypertensive drugs.
Next Document:  Ultrastructural localization of specific gonococcal macromolecules with antibody-gold sphere immunol...